Statut
NA
non disponible
Partager
Données de financement (31/01/2020)
Collecté
EUR
766 042,00
Cible minimum
EUR
500 000,00
DĂ©tails
Pays
Finlande
Secteur
SantéBiotechnology
Date de fin
31/01/2020
(1997 jours)
Description
“Askel offers a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a medical device already on the 250M€ market for animal health with excellent clinical results. The next step is to enter into the 2.2B$ human market.”